XTL Biopharma (XTLB) Reports Q3 Breakeven Loss
Tweet
Share
E-mailGet Alerts XTLB Hot Sheet
Join SI Premium – FREE
XTL Biopharma (NASDAQ: XTLB) reported Q3 EPS of $-0.00, versus $-0.00 reported last year.
For earnings history and earnings-related data on XTL Biopharma (XTLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Dare Bioscience (DARE) Tops Q2 EPS by 11c
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
